Baxter International Inc. BAX.VI Stock
Baxter International Inc. Price Chart
Baxter International Inc. BAX.VI Financial and Trading Overview
Baxter International Inc. stock price | 38.62 EUR |
Previous Close | 39.95 EUR |
Open | 39.95 EUR |
Bid | 39.55 EUR x 0 |
Ask | 41.3 EUR x 0 |
Day's Range | 39.95 - 39.95 EUR |
52 Week Range | 35.36 - 66.15 EUR |
Volume | 0 EUR |
Avg. Volume | 0 EUR |
Market Cap | 20.37B EUR |
Beta (5Y Monthly) | 0.568661 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.14 EUR |
Forward Dividend & Yield | 1.08 (2.65%) |
Ex-Dividend Date | June 1, 2023 |
1y Target Est | N/A |
BAX.VI Valuation Measures
Enterprise Value | 35.49B EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.3531917 |
Price/Book (mrq) | 3.4374464 |
Enterprise Value/Revenue | 2.357 |
Enterprise Value/EBITDA | 11.47 |
Trading Information
Baxter International Inc. Stock Price History
Beta (5Y Monthly) | 0.568661 |
52-Week Change | -36.56% |
S&P500 52-Week Change | 20.43% |
52 Week High | 66.15 EUR |
52 Week Low | 35.36 EUR |
50-Day Moving Average | 39.67 EUR |
200-Day Moving Average | 45.65 EUR |
BAX.VI Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 505.85M |
Float | 504.15M |
Short Ratio | N/A |
% Held by Insiders | 0.24% |
% Held by Institutions | 83.98% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.16 |
Trailing Annual Dividend Yield | 2.90% |
5 Year Average Dividend Yield | 130.00% |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -16.33% |
Operating Margin (ttm) | 11.63% |
Gross Margin | 39.04% |
EBITDA Margin | 20.55% |
Management Effectiveness
Return on Assets (ttm) | 3.59% |
Return on Equity (ttm) | -32.52% |
Income Statement
Revenue (ttm) | 15.05B EUR |
Revenue Per Share (ttm) | 29.84 EUR |
Quarterly Revenue Growth (yoy) | -1.60% |
Gross Profit (ttm) | 6.03B EUR |
EBITDA | 3.09B EUR |
Net Income Avi to Common (ttm) | -2460000000 EUR |
Diluted EPS (ttm) | -4.5 |
Quarterly Earnings Growth (yoy) | -38.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 1.67B EUR |
Total Cash Per Share (mrq) | 3.31 EUR |
Total Debt (mrq) | 16.89B EUR |
Total Debt/Equity (mrq) | 284.28 EUR |
Current Ratio (mrq) | 1.701 |
Book Value Per Share (mrq) | 11.622 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.48B EUR |
Levered Free Cash Flow (ttm) | 1.17B EUR |
Profile of Baxter International Inc.
Country | Austria |
State | IL |
City | Deerfield |
Address | One Baxter Parkway |
ZIP | 60015 |
Phone | 224 948 2000 |
Website | https://www.baxter.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 60000 |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.
Q&A For Baxter International Inc. Stock
What is a current BAX.VI stock price?
Baxter International Inc. BAX.VI stock price today per share is 38.62 EUR.
How to purchase Baxter International Inc. stock?
You can buy BAX.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Baxter International Inc.?
The stock symbol or ticker of Baxter International Inc. is BAX.VI.
Which industry does the Baxter International Inc. company belong to?
The Baxter International Inc. industry is Medical Instruments & Supplies.
How many shares does Baxter International Inc. have in circulation?
The max supply of Baxter International Inc. shares is 509.35M.
What is Baxter International Inc. Price to Earnings Ratio (PE Ratio)?
Baxter International Inc. PE Ratio is now.
What was Baxter International Inc. earnings per share over the trailing 12 months (TTM)?
Baxter International Inc. EPS is -0.14 EUR over the trailing 12 months.
Which sector does the Baxter International Inc. company belong to?
The Baxter International Inc. sector is Healthcare.